U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9390193901A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive LozengeCompletedNo Results AvailableTobacco Use Disorder|SmokingOther: Ariva Silver Wintergreen|Other: Placebo Wintergreenhttps://ClinicalTrials.gov/show/NCT01336816
9390293902Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRIRecruitingNo Results AvailableBone Cancer|Chondrosarcoma|Ewing's Sarcoma|Osteosarcoma|RhabdomyosarcomaDrug: Feraheme|Procedure: MR Scanhttps://ClinicalTrials.gov/show/NCT01336803
9390393903National Lymphatic Disease and Lymphedema RegistryRecruitingNo Results AvailableLymphedemahttps://ClinicalTrials.gov/show/NCT01336790
9390493904Regional Fat Depots and Insulin ResistanceActive, not recruitingNo Results AvailableObesity|Insulin Resistance|Diabetes Mellitus Type 2https://ClinicalTrials.gov/show/NCT01336777
9390593905Enhancing Emotion Regulation During Driving in OEF/OIF VeteransRecruitingNo Results AvailableDriving Distress Secondary to Trauma During DeploymentBehavioral: Cognitive reappraisal and breathing retraining|Behavioral: Controlhttps://ClinicalTrials.gov/show/NCT01336764
9390693906Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination TreatmentCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Insulin glargine|Drug: 75% insulin lispro protamine suspension and 25 % insulin lispro injectionhttps://ClinicalTrials.gov/show/NCT01336751
9390793907Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes MellitusCompletedHas ResultsDiabetes, Type 2Drug: Placebo|Drug: 150 mg PF-04991532|Drug: 450 mg PF-04991532|Drug: 750 mg PF-04991532|Drug: Sitagliptin 100 mghttps://ClinicalTrials.gov/show/NCT01336738
9390893908Learning and Coping With Chronic IllnessCompletedNo Results AvailableMorbid ObesityBehavioral: Teaching life style changes|Other: Active participation|Other: Teachinghttps://ClinicalTrials.gov/show/NCT01336725
9390993909Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic DiseasesActive, not recruitingNo Results AvailableChronic Leukemia|Acute Leukemia|Hodgkin's Disease|Non-Hodgkin's Lymphoma|Myelodysplastic SyndromeProcedure: Peripheral Blood Stem Cell Transplanthttps://ClinicalTrials.gov/show/NCT01336712
9391093910Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3RecruitingNo Results AvailableShigella InfectionBiological: WRSs3|Biological: WRSs2|Other: Placebohttps://ClinicalTrials.gov/show/NCT01336699
9391193911Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedNo Results AvailableHyperuricemia|GoutDrug: Arhalofenate|Drug: Arhalofenate|Drug: Placebo comparator|Drug: Colchicinehttps://ClinicalTrials.gov/show/NCT01336686
9391293912Glucophage XR® Observational StudyTerminatedNo Results AvailableDiabetes Mellitus Type 2|GI Side Effecthttps://ClinicalTrials.gov/show/NCT01336673
9391393913A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in MoroccoNot yet recruitingNo Results AvailablePoisoning by Scorpion StingBiological: equine F(ab')2 antivenom|Other: Standard of care plus placebohttps://ClinicalTrials.gov/show/NCT01336660
9391493914An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice InfestationCompletedHas ResultsPediculosisDrug: Group A - Low-Dose Ha44 0.37% w/w|Drug: Group B - High Dose Ha44 Gel 0.74% w/w|Drug: Group C - Placebohttps://ClinicalTrials.gov/show/NCT01336647
9391593915Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell RecruitingNo Results AvailableCancerDrug: Dabrafenib|Device: Trametinibhttps://ClinicalTrials.gov/show/NCT01336634
9391693916Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS).Active, not recruitingNo Results AvailableEpilepsyDrug: Retigabine IRhttps://ClinicalTrials.gov/show/NCT01336621
9391793917A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPDCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: Fluticasone Furoate/Vilanterol|Drug: Vilanterol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01336608
9391893918Comparison of Total Knee Arthroplasties With Oxidized Zirconium and Cobalt Chromium Femoral ComponentsCompletedNo Results AvailableOsteoarthritisDevice: Zirconium (Zirconium Genesis II)|Device: Cobalt-Chrome (Cobalt Chrome Genesis II)https://ClinicalTrials.gov/show/NCT01336595
9391993919Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid CancerCompletedNo Results AvailableSolid TumorDrug: taxoterehttps://ClinicalTrials.gov/show/NCT01336582
9392093920Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololCompletedHas ResultsGlaucomaDrug: Travoprost 0.004%/timolol maleate 0.5% fixed combinationhttps://ClinicalTrials.gov/show/NCT01336569
9392193921Titration of Continuous Positive Airway Pressure Could Predict Success of Oral Appliance to Treat Sleep ApneaRecruitingNo Results AvailableObstructive Sleep ApneaProcedure: Oral appliancehttps://ClinicalTrials.gov/show/NCT01336556
9392293922Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)WithdrawnNo Results AvailableStage III Non-small Cell Lung CancerDrug: Chemotherapy following concurrent Chemoradiotherapyhttps://ClinicalTrials.gov/show/NCT01336543
9392393923Tepilta® Versus Oxetacaine, Antacids and PlaceboRecruitingNo Results AvailableRadiation-induced OesophagitisDrug: oxetacaine, aluminium and magnesium hydroxide|Drug: oxetacaine|Drug: magnesium and aluminium hydroxide|Other: Vehiclehttps://ClinicalTrials.gov/show/NCT01336530
9392493924Evaluation of the Effect of an Ankle Foot Orthoses for Ambulatory FunctionCompletedNo Results AvailableHemiplegia, Spastichttps://ClinicalTrials.gov/show/NCT01336517
9392593925CD56+CD3- NK Cells Following Allogeneic Stem Cell TransplantationWithdrawnNo Results AvailableHaematological Malignancies|Allogeneic Stem Cell Transplant|CD56+CD3- NK CellsProcedure: Infusion of donor derived ex-vivo selected NK cells to patients after transplant|Procedure: Haematology / Blood chemistry samplinghttps://ClinicalTrials.gov/show/NCT01336478
9392693926Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative ColitisCompletedNo Results AvailableUlcerative ColitisDrug: placebo|Drug: rhuMAb Beta7https://ClinicalTrials.gov/show/NCT01336465
9392793927Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and BiomarkersRecruitingNo Results AvailableAdvanced Adult Hepatocellular CarcinomaRadiation: DCE MRIhttps://ClinicalTrials.gov/show/NCT01336452
9392893928Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep BruxismRecruitingNo Results AvailableSleep BruxismDrug: Botulinum toxin type A (Meditoxin®)https://ClinicalTrials.gov/show/NCT01336439
9392993929Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery DiseaseCompletedNo Results AvailablePeripheral Artery Diseasehttps://ClinicalTrials.gov/show/NCT01336426
9393093930Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF VeteransRecruitingNo Results AvailableBrain Injuries, TraumaticDrug: Pregnenolone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01336413

* Görseller ve İçerik tekif hakkına sahip olabilir